Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Matchima Laowansiri"'
Autor:
Aye Mya Sithu Shein, Dhammika Leshan Wannigama, Cameron Hurst, Peter N. Monk, Mohan Amarasiri, Vishnu Nayak Badavath, Phatthranit Phattharapornjaroen, William Graham Fox Ditcham, Puey Ounjai, Thammakorn Saethang, Naphat Chantaravisoot, Wanwara Thuptimdang, Sirirat Luk-in, Sumanee Nilgate, Ubolrat Rirerm, Chanikan Tanasatitchai, Naris Kueakulpattana, Matchima Laowansiri, Tingting Liao, Rosalyn Kupwiwat, Rojrit Rojanathanes, Natharin Ngamwongsatit, Arsa Thammahong, Hitoshi Ishikawa, Daniel Pletzer, Asada Leelahavanichkul, Naveen Kumar Devanga Ragupathi, Pattama Wapeesittipan, S.M. Ali Hosseini Rad, Talerngsak Kanjanabuch, Robin James Storer, Kazuhiko Miyanaga, Longzhu Cui, Hiroshi Hamamoto, Paul G. Higgins, Anthony Kicic, Tanittha Chatsuwan, Parichart Hongsing, Shuichi Abe
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 168, Iss , Pp 115793- (2023)
Given the rise of multidrug-resistant (MDR) Pseudomonas aeruginosa infections, alternative treatments are needed. Anti-pseudomonal phage therapy shows promise, but its clinical application is limited due to the development of resistance and a lack of
Externí odkaz:
https://doaj.org/article/22d07a84b4d4456386d246774c930d26
Autor:
Dhammika Leshan Wannigama, Aye Mya Sithu Shein, Cameron Hurst, Peter N. Monk, Parichart Hongsing, Phatthranit Phattharapornjaroen, William Graham Fox Ditcham, Puey Ounjai, Thammakorn Saethang, Naphat Chantaravisoot, Pattama Wapeesittipan, Sirirat Luk-in, Sasipen Sae-Joo, Sumanee Nilgate, Ubolrat Rirerm, Chanikan Tanasatitchai, Naris Kueakulpattana, Matchima Laowansiri, Tingting Liao, Rosalyn Kupwiwat, Rojrit Rojanathanes, Natharin Ngamwongsatit, Somkanya Tungsanga, Asada Leelahavanichkul, Naveen Kumar Devanga Ragupathi, Vishnu Nayak Badavath, S.M. Ali Hosseini Rad, Talerngsak Kanjanabuch, Nattiya Hirankarn, Robin James Storer, Longzhu Cui, Mohan Amarasiri, Hitoshi Ishikawa, Paul G. Higgins, Stephen M. Stick, Anthony Kicic, Tanittha Chatsuwan, Shuichi Abe
Publikováno v:
iScience, Vol 26, Iss 7, Pp 107215- (2023)
Summary: Developing an effective therapy to overcome carbapenemase-positive Klebsiella pneumoniae (CPKp) is an important therapeutic challenge that must be addressed urgently. Here, we explored a Ca-EDTA combination with aztreonam or ceftazidime-avib
Externí odkaz:
https://doaj.org/article/692a14fe4d374bc2bbbc7bb2b78a959c
Autor:
Aye Mya Sithu Shein, Dhammika Leshan Wannigama, Paul G. Higgins, Cameron Hurst, Shuichi Abe, Parichart Hongsing, Naphat Chantaravisoot, Thammakorn Saethang, Sirirat Luk-in, Tingting Liao, Sumanee Nilgate, Ubolrat Rirerm, Naris Kueakulpattana, Sukrit Srisakul, Apichaya Aryukarn, Matchima Laowansiri, Lee Yin Hao, Manta Yonpiam, Naveen Kumar Devanga Ragupathi, Teerasit Techawiwattanaboon, Natharin Ngamwongsatit, Mohan Amarasiri, Puey Ounjai, Rosalyn Kupwiwat, Phatthranit Phattharapornjaroen, Vishnu Nayak Badavath, Asada Leelahavanichkul, Anthony Kicic, Tanittha Chatsuwan
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-19 (2022)
Abstract The global prevalence of colistin-resistant Klebsiella pneumoniae (ColRkp) facilitated by chromosomal and plasmid-mediated Ara4N or PEtN-remodeled LPS alterations has steadily increased with increased colistin usage for treating carbapenem-r
Externí odkaz:
https://doaj.org/article/27b9dd068f2d40ec85484307aa6c2528
Autor:
Aye Mya Sithu Shein, Dhammika Leshan Wannigama, Paul G. Higgins, Cameron Hurst, Shuichi Abe, Parichart Hongsing, Naphat Chantaravisoot, Thammakorn Saethang, Sirirat Luk-in, Tingting Liao, Sumanee Nilgate, Ubolrat Rirerm, Naris Kueakulpattana, Matchima Laowansiri, Sukrit Srisakul, Netchanok Muhummudaree, Teerasit Techawiwattanaboon, Lin Gan, Chenchen Xu, Rosalyn Kupwiwat, Phatthranit Phattharapornjaroen, Rojrit Rojanathanes, Asada Leelahavanichkul, Tanittha Chatsuwan
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract Development of an effective therapy to overcome colistin resistance in Klebsiella pneumoniae, a common pathogen causing catheter-related biofilm infections in vascular catheters, has become a serious therapeutic challenge that must be addres
Externí odkaz:
https://doaj.org/article/491ac0c3946b44bdaec80c89ea6845a3
Autor:
Peerada Sermswan, Rakwaree Sriharat, Supichcha Saithong, Matchima Laowansiri, Nutchaya Amornruk, Direkrit Chiewchengchol, Nopadon Noppakun, Pravit Asawanonda, Tanittha Chatsuwan, Chanat Kumtornrut
Publikováno v:
The Journal of Dermatology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02e964cb9de5cf720a2bfddb77602093
https://doi.org/10.1111/1346-8138.16823
https://doi.org/10.1111/1346-8138.16823
Autor:
Sumanee Nilgate, Aye Mya Sithu Shein, Netchanok Muhummudaree, Asada Leelahavanichkul, Naris Kueakulpattana, Rojrit Rojanathanes, Ubolrat Rirerm, Sukrit Srisakul, Dhammika Leshan Wannigama, Shuichi Abe, Rosalyn Kupwiwat, Tanittha Chatsuwan, Phatthranit Phattharapornjaroen, Lin Gan, Cameron Hurst, Parichart Hongsing, Chenchen Xu, Teerasit Techawiwattanaboon, Paul G. Higgins, Thammakorn Saethang, Naphat Chantaravisoot, Matchima Laowansiri, Tingting Liao, Sirirat Luk-in
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Development of an effective therapy to overcome colistin resistance in Klebsiella pneumoniae, a common pathogen causing catheter-related biofilm infections in vascular catheters, has become a serious therapeutic challenge that must be addressed urgen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c02f3fa44060284863607896a805905
https://doi.org/10.1038/s41598-021-01052-5
https://doi.org/10.1038/s41598-021-01052-5
Autor:
Dhammika Leshan Wannigama, Paul G Higgins, Cameron Hurst, Shuichi Abe, Parichart Hongsing, Sirirat Luk-In, Naris Kueakulpattana, Matchima Laowansiri, Chanikan Tanasatitchai, Sukrit Srisakul, Anthony Kicic, Tanittha Chatsuwan, Samir Moussa, Alita Miller
Publikováno v:
Open Forum Infectious Diseases. 8:S628-S629
Background Due to the increase in multi-drug resistance (MDR) of Acinetobacter baumannii chronic infections with accompanying considerable morbidity and mortality, it is imperative to find effective novel treatments. Durlobactam (DUR) is a potent bro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f8a7481e62c6c111b10e2595c19e640
https://doi.org/10.1093/ofid/ofab466.1267
https://doi.org/10.1093/ofid/ofab466.1267